134 related articles for article (PubMed ID: 26768192)
41. EUS Needle Identification Comparison and Evaluation study (with videos).
Tang SJ; Vilmann AS; Saftoiu A; Wang W; Streba CT; Fink PP; Griswold M; Wu R; Dietrich CF; Jenssen C; Hocke M; Kantowski M; Pohl J; Fockens P; Annema JT; van der Heijden EH; Havre RF; Pham KD; Kunda R; Deprez PH; Mariana J; Vazquez-Sequeiros E; Larghi A; Buscarini E; Fusaroli P; Lahav M; Puri R; Garg PK; Sharma M; Maluf-Filho F; Sahai A; Brugge WR; Lee LS; Aslanian HR; Wang AY; Shami VM; Markowitz A; Siddiqui AA; Mishra G; Scheiman JM; Isenberg G; Siddiqui UD; Shah RJ; Buxbaum J; Watson RR; Willingham FF; Bhutani MS; Levy MJ; Harris C; Wallace MB; Nolsøe CP; Lorentzen T; Bang N; Sørensen SM; Gilja OH; D'Onofrio M; Piscaglia F; Gritzmann N; Radzina M; Sparchez ZA; Sidhu PS; Freeman S; McCowan TC; de Araujo CR; Patel A; Ali MA; Campbell G; Chen E; Vilmann P
Gastrointest Endosc; 2016 Sep; 84(3):424-433.e2. PubMed ID: 26873530
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments.
Lam C; Liu WF; Bel RD; Chan K; Miller L; Brown MC; Chen Z; Cheng D; Patel D; Xu W; Darling GE; Liu G
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26822871
[TBL] [Abstract][Full Text] [Related]
43. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.
Gyawali CP; Carlson DA; Chen JW; Patel A; Wong RJ; Yadlapati RH
Am J Gastroenterol; 2020 Sep; 115(9):1412-1428. PubMed ID: 32769426
[TBL] [Abstract][Full Text] [Related]
44. Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders.
Li X; Ding F; Luo P; Yang J; Liu Z; Liu J; Zhang Y; Leng A; Wu K
Front Psychiatry; 2018; 9():115. PubMed ID: 29867593
[TBL] [Abstract][Full Text] [Related]
45. Risk Factors for Gastroesophageal Reflux Disease in Saudi Arabia.
Alkhathami AM; Alzahrani AA; Alzhrani MA; Alsuwat OB; Mahfouz MEM
Gastroenterology Res; 2017 Oct; 10(5):294-300. PubMed ID: 29118870
[TBL] [Abstract][Full Text] [Related]
46. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
Mahoney LB; Nurko S; Rosen R
J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
[TBL] [Abstract][Full Text] [Related]
47. Between GERD and NERD: the relevance of weakly acidic reflux.
de Bortoli N; Ottonello A; Zerbib F; Sifrim D; Gyawali CP; Savarino E
Ann N Y Acad Sci; 2016 Sep; 1380(1):218-229. PubMed ID: 27472432
[TBL] [Abstract][Full Text] [Related]
48. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
50. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
51. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
52. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
53. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
54. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
Vardar R; Keskin M
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
